Arkolith/Insider Trading/COEP/Form 4

Cogley Brian

Chief Financial OfficerCoeptis Therapeutics Holdings, Inc. (COEP) · full profile →Form 4 · filed Feb 13, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2026Grant(A)13K—$023K
Feb 11, 2026Option exercise(M)10K$10.56$106K23K

Transaction Codes

A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-26-001032) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML